2m 2m 2m 2m 2m 2m 2m
Codexis (CDXS)
NASDAQ
$1.67+$0.003 (+0.18%)
Price as of Aug 21, 2026 7:57 PM EDT- $182.9MMarket Cap
- -42.11%1-Year Change
- BiotechnologyIndustry
Codexis (CDXS)
$1.67+$0.003 (+0.18%)
CDXS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.67 | ||
Change | +$0.09 (+5.70%) | ||
Open | $1.60 | ||
High | $1.70 | ||
Low | $1.58 | ||
Previous Close | $1.58 | ||
Volume | 1,257,998 | ||
30-Day Average Volume | 1,667,961 | ||
1-Week Change | 7.05% | ||
1-Month Change | -24.09% | ||
1-Year Change | -42.11% | ||
3-Year Change | -3.47% | ||
5-Year Change | -92.69% | ||
Fundamentals | |||
Shares Outstanding | 109.5M | ||
Total Assets | $120.1M | ||
Market Cap | $182.9M | ||
Enterprise Value | $196.6M | ||
Period: QTR TTM FY | |||
Revenue | $13.2M | ||
Net Income | -$12.0M | ||
Free Cash Flow | -$10.5M | ||
EBIT | -$10.7M | ||
EBITDA | -$9.5M | ||
Net Working Capital | $48.4M | ||
EPS | -$0.13 | ||
Enterprise Value/EBITDA | -21 | ||
Enterprise Value/Revenue | 15 | ||
P/B | 6 | ||
P/E | -13 | ||
PEG | 0 | ||
Price/Free Cash Flow | -17 | ||
Price/Operating Cash Flow | -19 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue